Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.

Artemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment...

Full description

Bibliographic Details
Main Authors: Fairhurst, R, Nayyar, G, Breman, J, Hallett, R, Vennerstrom, J, Duong, S, Ringwald, P, Wellems, T, Plowe, C, Dondorp, A
Format: Journal article
Language:English
Published: 2012
_version_ 1797061384591114240
author Fairhurst, R
Nayyar, G
Breman, J
Hallett, R
Vennerstrom, J
Duong, S
Ringwald, P
Wellems, T
Plowe, C
Dondorp, A
author_facet Fairhurst, R
Nayyar, G
Breman, J
Hallett, R
Vennerstrom, J
Duong, S
Ringwald, P
Wellems, T
Plowe, C
Dondorp, A
author_sort Fairhurst, R
collection OXFORD
description Artemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment of malaria. Recognizing the significance and immediacy of this possibility, the Fogarty International Center and the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health convened a conference in November 2010 to bring together the diverse array of stakeholders responding to the growing threat of artemisinin resistance, including scientists from malarious countries in peril. This conference encouraged and enabled experts to share their recent unpublished data from studies that may improve our understanding of artemisinin resistance. Conference sessions addressed research priorities to forestall artemisinin resistance and fostered collaborations between field- and laboratory-based researchers and international programs, with the aim of translating new scientific evidence into public health solutions. Inspired by this conference, this review summarizes novel findings and perspectives on artemisinin resistance, approaches for translating research data into relevant public health information, and opportunities for interdisciplinary collaboration to combat artemisinin resistance.
first_indexed 2024-03-06T20:30:21Z
format Journal article
id oxford-uuid:30d491e2-6e08-4a25-acd3-5fd5b6b084c1
institution University of Oxford
language English
last_indexed 2024-03-06T20:30:21Z
publishDate 2012
record_format dspace
spelling oxford-uuid:30d491e2-6e08-4a25-acd3-5fd5b6b084c12022-03-26T13:03:58ZArtemisinin-resistant malaria: research challenges, opportunities, and public health implications.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:30d491e2-6e08-4a25-acd3-5fd5b6b084c1EnglishSymplectic Elements at Oxford2012Fairhurst, RNayyar, GBreman, JHallett, RVennerstrom, JDuong, SRingwald, PWellems, TPlowe, CDondorp, AArtemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment of malaria. Recognizing the significance and immediacy of this possibility, the Fogarty International Center and the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health convened a conference in November 2010 to bring together the diverse array of stakeholders responding to the growing threat of artemisinin resistance, including scientists from malarious countries in peril. This conference encouraged and enabled experts to share their recent unpublished data from studies that may improve our understanding of artemisinin resistance. Conference sessions addressed research priorities to forestall artemisinin resistance and fostered collaborations between field- and laboratory-based researchers and international programs, with the aim of translating new scientific evidence into public health solutions. Inspired by this conference, this review summarizes novel findings and perspectives on artemisinin resistance, approaches for translating research data into relevant public health information, and opportunities for interdisciplinary collaboration to combat artemisinin resistance.
spellingShingle Fairhurst, R
Nayyar, G
Breman, J
Hallett, R
Vennerstrom, J
Duong, S
Ringwald, P
Wellems, T
Plowe, C
Dondorp, A
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
title Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
title_full Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
title_fullStr Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
title_full_unstemmed Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
title_short Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.
title_sort artemisinin resistant malaria research challenges opportunities and public health implications
work_keys_str_mv AT fairhurstr artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT nayyarg artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT bremanj artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT hallettr artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT vennerstromj artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT duongs artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT ringwaldp artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT wellemst artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT plowec artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications
AT dondorpa artemisininresistantmalariaresearchchallengesopportunitiesandpublichealthimplications